CompletedPHASE2, PHASE3NCT01285583
Safety Extension Study of TRO19622 in ALS
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hoffmann-La Roche
- Principal Investigator
- Vincent Meininger, MD, PhDGroupe Hospitalier Pitie-Salpetriere
- Intervention
- TRO19622(drug)
- Enrollment
- 271 enrolled
- Eligibility
- All sexes
- Timeline
- 2010 – 2012
Study locations (15)
- University Hospital Gasthuisberg - Dept Neurology - Herestraat 49, Leuven, Belgium
- HCL Hôpital Neurologique et Neurochirurgical Pierre Wertheimer - Neurologie C et Laboratoire d'électromyographie - 59, boulevard Pinel, Bron, France
- CHRU de LILLE - Hôpital Roger Salengro - Centre SLA-MMN - Sce de Neurologie et Pathologie du Mouvement, Lille, France
- Centre SLA Limoges - Service de Neurologie, Limoges, France
- Hôpital La Timone - Service Neurologie et Maladies Neuromusculaires, Marseille, France
- Clinique du Motoneurone - Sce d'Explorations Neurologiques - Hôpital Gui de Chauliac, Montpellier, France
- CHU de Nice - Hôpital de l'Archet 1 - Centre de Référence pour les Maladies Neuromusculaires et la SLA, Nice, France
- Groupe Hospitalier PITIE-SALPETRIERE - Fédération des Maladies du Système Nerveux, Paris, France
- Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, Neurologische Poliklinik Ambulanz für ALS und andere Motoeneuronenerkrankungen, Berlin, Germany
- Universitätsklinik und Poliklinik für Neurologie - Martin-Luther-Universität Halle-Wittenberg, Halle, Germany
- Neurologische Klinik Medizinische Hochschule, Hanover, Germany
- Universitäts- und Rehabilitationskliniken Ulm (RKU) - Neurologische Universitätsklinik, Ulm, Germany
- Hospital Carlos III - Unidad de ELA - Sinesio Delgado, 10, Madrid, Spain
- King's MND Care and Research Center - Academic Neurosciences Building PO Box 41 Institute of Psychiatry, London, United Kingdom
- Academic Neurology Unit - University of Sheffield - Section of Neuroscience - Division of Genomic Medicine - School of Medicine and Biomedical Sciences, Sheffield, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01285583 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)
- RECRUITINGPHASE3NCT07322003Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALSPrilenia